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PRELIMINARY AND SHORT REPORTS 
PYRIBENZAMINE IN THERAPY AND PROPHYLAXIS OF 
RHUS DERMATITIS 
DANIEL c. TWEEDALL, M.D . , AND WILLIAM B. O'CONNOR, M .D .l 
We wish to present the. results of clinical experiments in artificially induced dermatitis 
venenata (Rhus toxicodendron). Mayer (1) concluded that histamine or a histamine-like 
substance does play an active role in the production of epidermal inflammation, whether it 
is produced by an irritant or by an antigen . Osborne (2), however, in a study of fifteen 
cases of dermatitis venenata, most of whom were originally patients with industrial derma-
toses, found that Pyribenzamine did not appear to influence in any way the course of the 
eruption, nor did it produce any relief of symptoms. The following study was made in an 
effort to observe the effect of Pyribenzamine in lthus Dermatitis under controlled condi-
tions. 
Twenty-eight individuals were picked at random and patch tested with a 1:10 dilution 
of Rhus toxicodendron extract in acetone . A site on the flexor surface of the right forearm 
was selected and an area 0.5 em . in diameter was painted with the Rhus extract, allowed to 
dry, and then covered with a light gauze dressing. At the same time, a similar area was 
tested using the vehicle, acetone, as a control. The patch tests were left in place for 
twenty-four hours; then removed, and the areas cleansed with soap and water. 
The reactions were classified as follows : 
No reaction... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Negative 
Mild erythema . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . One plus reaction 
Marked erythema .. . . . . .... ... ..... . . ...... . ....... . ... .. . Two plus reaction 
Edema or wheal. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Three plus reaction 
Vesiculation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Four plus reaction 
Readings were made at twenty-four hour intervals and the reactions recorded. None of 
the subjects was sensitive to the control. At the end of four days, there were five 4 plus 
reactions, no 3 plus reactions, one 2 plus reaction, and four 1 plus reactions. 
On the sixth day, all individuals showing a 4 plus reaction were again subjected to patch 
tests according to the above procedure, only this time the left arm was used. One hour 
before application, 100 mgms. of Pyribenzamine were given orally; then 50 mgms. at the 
time of application, and 50 mgms. every four hours for twenty-four hours thereafter, or a 
total of 400 mgms. We found that the degree of vesiculation was not influenced by the 
administration of the drug, and only one individual reported some relief of the subjective 
symptoms of burning and itching. 
CONCLUSION 
The antihistamine drug Pyribenzamine was found to be of no value in the prevention of 
Rhus dermatitis, a.s employed in this experiment, and was only moderately effective in 
relieving the subjective symptoms of itching and burning. These findings tend to sub-
stantiate the work of Osborne et al. (2) . 
I Pyribenzamine was supplied through the courtesy of the Ciba Pharmaceutical Prod-
ucts, Inc. 
Department of Dermatology and Syphilology, St . Mary's Group of Hospitals of St . 
Louis University School of Medicine; Ga.rold V. Stryker, M .D ., Director . 
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